Switching to a Bictegravir Single Tablet Regimen in Elderly People Living with HIV-1: Data Analysis from the BICTEL Cohort

Switching to a Bictegravir Single Tablet Regimen in Elderly People Living with HIV-1: Data Analysis from the BICTEL Cohort

Bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC/FTC/TAF) is a recommended once-daily single tablet regimen for the treatment of people living with HIV-1 (PLWH). We aimed to assess efficacy, safety and tolerability of BIC/FTC/TAF among PLWH, with a specific focus on people older than 55...

Full description

Bibliographic Details
Main Authors: Alessandro Lazzaro, Elio Gentilini Cacciola, Cristian Borrazzo, Giuseppe Pietro Innocenti, Eugenio Nelson Cavallari, Ivano Mezzaroma, Mario Falciano, Caterina Fimiani, Claudio Maria Mastroianni, Giancarlo Ceccarelli, Gabriella d’Ettorre
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Diagnostics
Subjects:
bictegravir
BIC/FTC/TAF
switch
HIV-1
HAART
antiretroviral
Online Access:https://www.mdpi.com/2075-4418/12/1/76

Internet

https://www.mdpi.com/2075-4418/12/1/76

Similar Items